Evidence map›Paper›PMID 41488837›Full record

ReviewAnnals of gastroenterological surgery2026

Essential Updates 2023/2024: Minimally Invasive Surgery for Biliary Tract Cancer.

Osamu Itano, Takuya Minagawa

Abstract readReview
In one paragraph

Review in Annals of gastroenterological surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Osamu ItanoDepartment of Hepato-Biliary-Pancreatic and Gastrointestinal Surgery, School of Medicine International University of Health and Welfare Chiba Japan.ORCID https://orcid.org/0000-0002-2197-9508
Takuya MinagawaDepartment of Hepato-Biliary-Pancreatic and Gastrointestinal Surgery, School of Medicine International University of Health and Welfare Chiba Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Minimally invasive surgery (MIS) for biliary tract cancer (BTC) has gained traction with advancements in laparoscopic and robotic techniques. However, its oncological impact remains uncertain. This review highlights key studies from 2023 and 2024 on MIS for BTC, including distal bile duct, hilar bile duct, gallbladder, and intrahepatic bile duct cancer. Although feasibility and safety are supported in experienced centers, long-term prognostic equivalence to open surgery remains debatable. Further studies are required to clarify surgical and oncological outcomes.

Indexed as

bile duct cancergallbladder cancerlaparoscopic liver resectionminimally invasive liver resectionrobot‐assisted liver resection

Identifiers

PMID41488837
PMCPMC12757154

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.